American Vietnamese Biotech (HSTC:AMV) Long-Term Debt: ₫0.00 Mil (As of . 20)


What is American Vietnamese Biotech Long-Term Debt?

American Vietnamese Biotech HSTC:AMV +7.69% Long-Term Debt is ₫0.00 Mil as of . 20.

American Vietnamese Biotech's Long-Term Debt for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech  (HSTC:AMV) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

American Vietnamese Biotech Long-Term Debt Related Terms

American Vietnamese Biotech Long-Term Debt Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Long-Term Debt Chart

American Vietnamese Biotech Annual Data
Trend
Long-Term Debt

American Vietnamese Biotech Quarterly Data
Long-Term Debt
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₫0.00 Mil mean?
American Vietnamese Biotech (HSTC:AMV) has a Long-Term Debt of ₫0.00 Mil as of . 20.
Is American Vietnamese Biotech's Long-Term Debt too high?
American Vietnamese Biotech's current Long-Term Debt is ₫0.00 Mil.
How does American Vietnamese Biotech's Long-Term Debt compare to HSTC and STLT?
American Vietnamese Biotech's Long-Term Debt of ₫0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. American Vietnamese Biotech's current Long-Term Debt is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current Long-Term Debt of ₫0.00 Mil. The current Long-Term Debt is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current Long-Term Debt is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.